Icon Group operates Australia’s largest private cancer clinical trials program with a growing reach into Asia and New Zealand. Icon brings together over 35 years’ experience in research and has an unwavering commitment to providing access to clinical trials to as many people as possible, as close
to home as possible.
Research is part of Icon’s DNA, and our international network of clinicians believe clinical trials are critical to the provision of exceptional cancer care. Within the private healthcare setting, Icon has an unparalleled track record of participating in national and international clinical trials across Phase I to
IV and lead the way in providing a quality, robust and efficient global clinical trials program.
Icon’s long-term commitment to clinical trials and emerging treatments is backed by peak industry partnerships. Research at Icon aims to provide more patients with opportunities previously not available to them by bringing tomorrow's treatments closer to today.
